Table 1.
Baseline characteristics of the patients in both groups
| ICG-FN (n = 57) | non-ICG-FN (n = 63) | p value | |
|---|---|---|---|
| Demographics | |||
| Gender (n, %) | 0.587a | ||
| Male | 38 (66.7) | 39 (61.9) | |
| Female | 19 (33.3) | 24 (38.1) | |
| Age (mean ± SD) | 57.3 ± 12.2 | 55.2 ± 12.5 | 0.341b |
| Lesion | |||
| Pathology type (n, %) | 0.455a | ||
| Malignant | 39 (68.4) | 39 (61.9) | |
| HCC | 28 | 30 | |
| ICC | 6 | 4 | |
| HCC/ICC mixed | 1 | 2 | |
| Other primary liver cancer | 1 | 0 | |
| Metastatic liver cancer | 3 | 3 | |
| Benign | 18 (31.6) | 24 (61.9) | |
| Hemangioma | 5 | 15 | |
| PEComa | 2 | 0 | |
| FNH | 4 | 0 | |
| Hepatolithiasis | 3 | 3 | |
| Inflammation and necrosis | 4 | 7 | |
| Number of involved lobes (n, %) | 0.969a | ||
| Single | 49 (86) | 54 (85.7) | |
| Multiple | 8 (14) | 9 (14.3) | |
| Diameter of measurable lesion [cm, median (1st/3rd quartiles, n)] | 4.5 (2.5–5.1, 54) | 4.5 (3.2–6.5, 60) | 0.263c |
| Liver function | |||
| Degree of cirrhosis (n, %) | 0.235a | ||
| ≦Mild | 43 (75.4) | 53 (84.1) | |
| ≧Moderate | 14 (24.6) | 10 (15.9) | |
| Volume of ascites (n, %) | 0.313a | ||
| None | 47 (82.5) | 56 (88.9) | |
| Mild | 10 (17.5) | 7 (11.1) | |
| ICG R15 [median (1st/3rd quartiles)] | 4.2 (2.1–7.4) | 3.7 (2.4–6.7) | 0.801 c |
ICG indocyanine green, FN fluorescence navigation, SD standard deviation, HCC hepatocellular carcinoma, ICC intrahepatic cholangiocarcinoma, PEComa perivascular epithelioid cell tumor, FNH focal nodular hyperplasia, ICG R15 ICG retention rate after 15 min
aPearson χ2 test
bStudent’s T test
cMann–Whitney U test